# Catalent Pharma Solutions, LLC – FDA Inspection, Feb 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/29026bc3-0257-48ed-98f2-f7393b135ed7
Source feed: FDA_Inspections

> FDA inspection 1199635 of Catalent Pharma Solutions, LLC, February 01, 2023. Classification: No Action Indicated (NAI). 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199635
- Company Name: Catalent Pharma Solutions, LLC
- Inspection Date: 2023-02-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1285382 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/ff8fc52d-bf9c-42ed-b3c5-9a5ec1212111)
- FDA Inspection 1063006 - 2018-07-13
- [FDA Inspection 1039238 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/84731a92-74a9-499d-98d1-6a1418cb216b)
- FDA Inspection 1024255 - 2017-08-21
- FDA Inspection 996931 - 2017-01-17

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anthony-j-donato/a6dd6e14-529e-4b23-9b5f-02c88afb80ae)
- [FDA Associated Person](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)
- [FDA Associated Person](https://www.keypedia.com/people/victoria-spivak/b43d066f-35c1-4d83-9d38-3ba64d77cf31)

Company: https://www.keypedia.com/companies/catalent-pharma-solutions-llc/311196d9-b80d-4a77-a294-dab360325781

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
